The use of human recombinant erythropoietin in chemotherapy-induced anemia. Experience with a Jehovah's Witness child
Barona Zamora, P.; Sierrasesúmaga Ariznavarreta, L.; Antillón Klüssmann, F.; Villa Elízaga, I.
Revista Clinica Espanola 193(9): 516-517
1993
ISSN/ISBN: 0014-2565 PMID: 8108589 Document Number: 406574
Document emailed within 1 workday
Related Documents
Velin, P.; Dupont, D.; Puig, C.; Golkar, A. 1993: Human recombinant erythropoietin and anemia in premature infants of parents who are Jehovah's Witnesses Archives Francaises de Pediatrie 50(8): 721-722Roungrong, J.; Teerawattananon, Y.; Chaikledkaew, U. 2008: Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand Journal of the Medical Association of Thailand 91(Suppl 2): S119-S125
Rebel, A.; Beck, A.; Efron, P.; Bavry, A.A.; Ang, D. 2015: Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness American Surgeon 81(6): E263-E265
Dyjas, R.; Wiecek, A.; Kokot, F. 1996: Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO Przeglad Lekarski 53(6): 486-490
Valladares Ayerbes, M.J.; Valenzuela Claros, J.C.; Reina Zoilo, J.J.; Ruiz Borrego, M.; Moreno Nogueira, J.A. 1997: Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma Anales de Medicina Interna 14(11): 593-594
Wang, T.S.; Lee, C.C.; Deng, H.H.; Lin, J.T.; Chang, J.S.; Lin, S.T. 1995: The effect of recombinant human erythropoietin in treating the anemia of prematurity Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 36(2): 121-127
Kakuk, G.; Kárpáti, I.; Mátyus, J. 1990: Recombinant human erythropoietin in the therapy of anemia in hemodialyzed patients Orvosi Hetilap 131(43): 2365-2366; 2369-2371
Abels, R.I. 1992: Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer Seminars in Oncology 19(3 Suppl 8: 29-35
Kącka, K.; Kącki, W.; Merak, J.; Błęka, A. 2010: Use of recombinant activated factor VII for reduction of perioperative blood loss during elective surgical correction of spine deformity in a Jehovah's Witness. Case report Ortopedia, Traumatologia, Rehabilitacja 12(5): 448-458
Henry, D.H. 1993: Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer Seminars in Hematology 30(4 Suppl 6: 12-16
Henry, D.H.; Beall, G.N.; Benson, C.A.; Carey, J.; Cone, L.A.; Eron, L.J.; Fiala, M.; Fischl, M.A.; Gabin, S.J.; Gottlieb, M.S. 1992: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials Annals of Internal Medicine 117(9): 739-748
Crawford, J. 2002: Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence Oncology 16(9 Suppl 10: 41-53
Wauters, J.P. 1990: Human recombinant erythropoietin: from clinical aspects to the physiopathology of anemia of renal insufficiency Revue Medicale de la Suisse Romande 110(11): 951-954
Lim, V.S. 1990: Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency? Seminars in Nephrology 10(2 Suppl. 1): 26-27
Boratyńska, M.; Szewczyk, Z.; Szepietowski, T.; Czyz, W.; Cybulski, K.; Bogucki, J.; Szczepański, J. 1990: Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis Przeglad Lekarski 47(11): 741-745
Rabbani, F. 2002: Dosing with recombinant human erythropoietin, used for treating early anemia of premature infants Likars'ka Sprava 2002(3-4): 81-84
Karwacki, M.; Ochocka, M.; Kubiak, W. 1994: Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients Przeglad Epidemiologiczny 48(4): 441-447
Hotta, T.; Ogawa, H.; Saito, A.; Ito, A. 1991: Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure International Journal of Hematology 54(3): 195-200
Adamson, W.; Egrie, J.C.; Browne, J.K.; Downing, M.R.; Eschbach, W. 1988: The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report Behring Institute Mitteilungen 1988(83): 188-192
Sulková, S.; Laurincová, Z.; Kvasnicka, J. 1990: Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients? Casopis Lekaru Ceskych 129(4): 113-115